IRCT2015062922968N1已完成未知
Evaluation of Carvedilol effect on LV function in patients treated with Herceptin due to breast cancer
Vice Chancellor for research of Hamedan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- Female
入选标准
- •inclusion criteria:
- •all of patient with breast cancer candidate for Herceptin therapy without attention to previous chemotherapy that have Ejection Fraction >50% and normal diastolic function or mild dysfunction
- •exclusion criteria:patient who have contraindication for Carvedilol;grade 2or 3 AV block; Heart rate <50;systolic blood pressure<90;Asthma;chronic obstructive pulmonary disease ;liver cirrhosis;psoriasis; peripheral vascular disease
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Effect of carvedilol on left ventricular systolic and diastolic function and the neurohormonal axis in patients with Duchenne muscular dystrophy and left ventricular dysfunction.EUCTR2006-003075-12-IEDepartment Of Paediatric Cardiology30
招募中
3 期
Evaluation of the effect of carvedilol in patients with gastrointestinal cancerGastrointestinal cancers (Esophageal cancer, Gastric cancer, Pancreatic cancer, Colon cancer).Malignant neoplasm of stomachIRCT20200907048646N1Ardabil University of Medical Sciences60
招募中
不适用
Carvedilol (drug) for liver diseaseCTRI/2022/01/039527Institute of Liver and Biliary Sciences
已完成
3 期
Evaluation of Early Disease in Familial Dilated CardiomyopathyFamilial dilated cardiomyopathyCardiovascular - Other cardiovascular diseasesACTRN12605000204640St Vincent's Hospital, Darlinghurst64
招募中
3 期
Effect of Carvedilol on Reducing Transtosomab Cardiac ComplicationsIRCT20190628044046N1Tehran University of Medical Sciences60